| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |